These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12674960)

  • 1. Off-label use of prescription medication: nursing implications.
    Keltz JM
    Nephrol Nurs J; 2003 Feb; 30(1):99-100. PubMed ID: 12674960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From off-label prescribing towards a new FDA.
    Tabarrok A
    Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label prescribing of medications for children.
    Monestime-Williams N; Dickerson LM; Basco WT
    J S C Med Assoc; 2007 Jun; 103(5):130-3. PubMed ID: 18333578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
    Joseph JN; Deaton D; Ehsan H; Bonanno MA
    J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacology and mental health nurse prescribers.
    Skingsley D; Bradley EJ; Nolan P
    J Clin Nurs; 2006 Aug; 15(8):989-97. PubMed ID: 16879543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital.
    Herring C; McManus A; Weeks A
    Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' attitudes towards, and information needs in relation to, nurse prescribing in rheumatology.
    Berry D; Bradlow A; Courtenay M
    J Clin Nurs; 2008 Jan; 17(2):266-73. PubMed ID: 18171396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use.
    Meadows WA; Hollowell BD
    Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
    Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
    J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurses' reported influence on the prescription and use of medication.
    Jutel A; Menkes DB
    Int Nurs Rev; 2010 Mar; 57(1):92-7. PubMed ID: 20487480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
    Chen H; Deshpande AD; Jiang R; Martin BC
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):629-38. PubMed ID: 15597329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off label drug promotion.
    Body Posit; 1998 Oct; 11(10):11. PubMed ID: 11365909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.